“Each vial is a life”. This is the core belief of Navesta. As a company that specialises in antibiotics, bringing awareness on how to utilise the drug responsibly is imperative. Antibiotic resistance is one of the world’s most dire public health issues as antibiotics are heavily relied on in medical practices to cure simple infections as well as utilised in surgical procedures.
Antibiotics revolutionised medicine and have saved millions of lives, even extending the average life expectancy significantly since its discovery.
On August 29, 2017, a day before Navesta’s inauguration, Navesta’s staff gathered for the company’s time capsule ceremony. Momentums from the past two years during the setup of the company were assembled and put into the containers which were buried on the company’s premises. In 25 years, the staff will hold another time capsule ceremony which they dig up the buried momentums and place additional items to be buried for the company’s 50th year anniversary.
Story Taken From DailyFT. Original Story Can Be Found Here: Navesta: Leading the charge in pharmaceutical manufacturing in Sri Lanka
Regionally, South Asia is a formidable force in pharmaceutical manufacturing. India and Bangladesh especially have risen tremendously in the last few decades in the international arena. The International Trade Center published that global sales from exported drugs and medicines totaled US$318.6 billion in 2016. India alone accounted for 3.6% of the world’s pharmaceutical exports,
Navesta Pharmaceuticals is a sterile manufacturer of Beta Lactam dry powder injectable products. Let’s break down what this means. Beta Lactam are a class of broad-spectrum antibiotics. Within the Beta Lactam class, there are different derivatives of antibiotics. Specifically, Navesta manufacturers the Penicillin category. Antibiotics can be manufactured in a variety of forms, pills, liquids, or injectables. Navesta manufactures dry powder forms of Penicillin. Dry powder injectable products are administered to patients by injecting the medicine directly into the patient’s blood.
Navesta Pharmaceuticals Opens Sri Lanka’s First Sterile Pharmaceutical Manufacturing Plant in Horana
Sri Lanka’s first EU-GMP, PIC/S compliant facility to enable exports of pharmaceuticals to international markets
Colombo, 30th August 2017: Navesta Pharmaceuticals Private Limited has set the benchmark for the local pharmaceutical manufacturing sector by opening the Country’s first sterile pharmaceutical manufacturing plant in Horana. Navesta Pharmaceuticals is Sri Lanka’s first European Union Good Manufacturing Practices (EU-GMP) and Pharmaceutical Inspection Co-Operation Scheme (PIC/S),
Navesta Pharmaceuticals (Private) Limited is soliciting proposals for an ERP system which will handle both corporate and manufacturing functionalities in multiple locations. The implementation of the ERP will be in Sri Lanka. Interested vendors please contact our purchasing agent representative at kris@navesta.com for instructions on how to participate and for the RFP document.
